Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes

Clin J Am Soc Nephrol. 2021 Sep;16(9):1407-1409. doi: 10.2215/CJN.02890221. Epub 2021 Jun 23.
No abstract available

Keywords: chronic renal insufficiency; diabetes; hyperkalemia; hypertension; patiromer; polymers; resistant hypertension; spironolactone.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Complications / complications
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Polymers / therapeutic use*
  • Renal Insufficiency, Chronic / complications
  • Spironolactone / therapeutic use*

Substances

  • Polymers
  • patiromer
  • Spironolactone